These data indicated that TRIM65 knockdown-induced autophagy inhibited cervical cancer by delivering the autophagosomes for degradation in the cancer cells, suggesting that TRIM65 may be a potential target for treatment of cervical cancer. This evidence concerns the gene TRIM65 and cervical carcinoma.